In obesity and type 2 diabetes, chronic hyperglycemia disrupts GI neuron activity by suppressing AMP-activated protein kinase (AMPK) and enhancing mammalian target of rapamycin (mTOR) signaling, leading to impaired nitric oxide (NO)-mediated insulin sensitivity. The gene discussed is MTOR; the disease is type 2 diabetes mellitus.